Eylea, Lucentis and Avastin Equally Effective in Treating Diabetic Macular Edema

February 19, 2015 2:03 PM

10 0

Eylea, Lucentis and Avastin Equally Effective in Treating Diabetic Macular Edema

A government-funded study found that three drugs available from $50 to $1,950 per dose were equally effective when it came to treating many cases of a common form of vision loss due to diabetes.

Out of all, Eylea sold by Regeneron Pharmaceuticals and the most expensive drug was the most effective for patients having poorer vision before the start of treatment.

Read more

To category page

Loading...